95 related articles for article (PubMed ID: 142589)
41. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
Matsuo O; Rijken DC; Collen D
Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
[TBL] [Abstract][Full Text] [Related]
42. Fluorescence polarization assay of plasmin, plasminogen, and plasminogen activator.
Kinoshita K; Maeda H; Hinuma Y
Anal Biochem; 1980 May; 104(1):15-22. PubMed ID: 6446247
[No Abstract] [Full Text] [Related]
43. Plasminogen activators in alcoholic cirrhosis: demonstration of increased tissue type and urokinase type activator.
Booth NA; Anderson JA; Bennett B
J Clin Pathol; 1984 Jul; 37(7):772-7. PubMed ID: 6235248
[TBL] [Abstract][Full Text] [Related]
44. [Releasing of plasminogen-activator from the kidney to the blood (author's transl)].
Nakata A; Hagita M; Okamoto U
Nihon Seirigaku Zasshi; 1978 Nov; 40(11):419-26. PubMed ID: 155161
[TBL] [Abstract][Full Text] [Related]
45. The evaluation of plasmin and streptokinase activator complexes in a new rabbit model of venous thrombosis.
Dupe RJ; English PD; Smith RA; Green J
Thromb Haemost; 1981 Aug; 46(2):528-34. PubMed ID: 6458112
[TBL] [Abstract][Full Text] [Related]
46. [New methods of studying the plasmin system using azofibrin].
Monastyrskiĭ VA; Gaĭda AV; Danysh TV; Magerovskiĭ IuV
Lab Delo; 1988; (10):49-53. PubMed ID: 2462090
[No Abstract] [Full Text] [Related]
47. The interaction of C1-esterase inhibitor and plasmin in human euglobulin.
Highsmith RF; Burnett CJ; Weirich CJ
J Lab Clin Med; 1979 Mar; 93(3):459-71. PubMed ID: 155127
[No Abstract] [Full Text] [Related]
48. Studies on activator formation in human plasma with streptokinase. III. Investigation of activator kinetics in undiluted plasma in terms of urokinase equivalents.
Martin M
Thromb Haemost; 1976 Dec; 36(3):566-81. PubMed ID: 138962
[TBL] [Abstract][Full Text] [Related]
49. QUANTITATIVE ESTIMATION OF UROKINASE AND BACTERIAL PLASMINOGEN ACTIVATORS USING A FIBRIN SUBSTRATE FORMED FROM PLASMINOGEN-FREE FIBRINOGEN.
ANDERSON AJ
Biochim Biophys Acta; 1963 Aug; 74():554-7. PubMed ID: 14071603
[No Abstract] [Full Text] [Related]
50. The interaction between heparin and plasmin on amidolysis.
Kohn S; Sakurama S; Morioka T; Ito Y; Yasukouchi T; Nakagawa S
Thromb Haemost; 1979 Dec; 42(4):1261-75. PubMed ID: 161669
[TBL] [Abstract][Full Text] [Related]
51. In vitro studies on the fibrinolytic, thrombolytic and fibrinogenolytic properties of a tissue plasminogen activator from guinea pig keratocytes.
Electricwala A; Ling RJ; Sutton PM; Griffiths B; Riley PA; Atkinson T
Thromb Haemost; 1985 Apr; 53(2):200-3. PubMed ID: 4040659
[TBL] [Abstract][Full Text] [Related]
52. Lower molecular weight species of alpha 2-macroglobulin-plasmin complexes in human plasma activated by urokinase.
Yamamoto J; Okamoto U
Nihon Ketsueki Gakkai Zasshi; 1985 Jul; 48(4):1090-9. PubMed ID: 2414954
[No Abstract] [Full Text] [Related]
53. Casein interference in bovine plasmin assays using a synthetic substrate.
Bastian ED; Brown RJ; Ernstrom CA
J Dairy Sci; 1991 Dec; 74(12):4119-24. PubMed ID: 1838556
[TBL] [Abstract][Full Text] [Related]
54. Alpha 2-plasmin inhibitor deficiency.
Lipinski B; Gurewich V
Lancet; 1979 Feb; 1(8111):329. PubMed ID: 84984
[No Abstract] [Full Text] [Related]
55. Effect of the cyanogen-bromide-2 fragment of fibrinogen on plasminogen activation by single-chain urokinase-type plasminogen activator.
Kirchheimer JC; Resch I; Christ G; Wojta J; Binder BR
Eur J Biochem; 1987 Jul; 166(2):393-7. PubMed ID: 3609016
[TBL] [Abstract][Full Text] [Related]
56. Interactions of plasminogen and fibrinogen with model silica glass surfaces: adsorption from plasma and enzymatic activity studies.
Woodhouse KA; Weitz JI; Brash JL
J Biomed Mater Res; 1994 Apr; 28(4):407-15. PubMed ID: 8006045
[TBL] [Abstract][Full Text] [Related]
57. Plasmin cleaves fibrinogen and the human complement proteins C3b and C5 in the presence of Leptospira interrogans proteins: A new role of LigA and LigB in invasion and complement immune evasion.
Castiblanco-Valencia MM; Fraga TR; Pagotto AH; Serrano SM; Abreu PA; Barbosa AS; Isaac L
Immunobiology; 2016 May; 221(5):679-89. PubMed ID: 26822552
[TBL] [Abstract][Full Text] [Related]
58. Proceedings: Influence of plasmin inhibitors on differentiating digestion between fibrinogenolysis and fibrinolysis.
Abe T; Kazama M
Thromb Diath Haemorrh; 1975 Nov; 34(2):584. PubMed ID: 53895
[No Abstract] [Full Text] [Related]
59. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage.
Zhang X; Chaudhry A; Chintala SK
Mol Vis; 2003 Jun; 9():238-48. PubMed ID: 12813409
[TBL] [Abstract][Full Text] [Related]
60. Serum inhibitors in fibrinolysis.
Gallimore MJ
Br J Haematol; 1975 Oct; 31(2):217-31. PubMed ID: 53065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
